CHARACTERIZATION OF NUCLEAR FACTOR-BINDING TO THE INTERLEUKIN-4 (IL-4) PROMOTER

被引：0
|
作者：
GEORAS, S
CASOLARO, V
WONG, S
SONG, Z
ONO, S
机构：
[1] JOHNS HOPKINS ASTHMA & ALLERGY CTR,DIV PULM & CRIT CARE MED,BALTIMORE,MD 21224
[2] JOHNS HOPKINS ASTHMA & ALLERGY,DIV ALLERGY & CLIN IMMUNOL,BALTIMORE,MD 21224
来源：
FASEB JOURNAL | 1994年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A778 / A778
页数：1
相关论文
共 50 条
  • [31] Osteoprotective effect by interleukin-4 (IL-4) on lipoprotein-induced periodontitis
    Teixeira, Jorge F. Lima
    Henning, Petra
    Magalhaes, Fernando A. Cintra
    Coletto-Nunes, Glaucia
    Floriano-Marcelino, Thais
    Westerlund, Anna
    Moverare-Skrtic, Sofia
    Oliveira, Guilherme J. P. L.
    Lerner, Ulf H.
    Souza, Pedro Paulo C.
    CYTOKINE, 2023, 172
  • [32] The polymorphism in interleukin-4 (IL-4) promoter region (C-590T) in Iranian patients with breast cancer
    Gharesi-Fard, B
    Talei, A
    Bavoli-Raftar, N
    Sarvari, J
    Rasouli, M
    Kamali-Sarvestani, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 155 - 155
  • [33] SPECIFICITIES AND CELL DISTRIBUTION OF TRANSCRIPTION FACTORS BINDING TO THE INTERLEUKIN-4 (IL-4) NEGATIVE REGULATORY ELEMENT (NRE)
    CASOLARO, V
    GEORAS, SN
    WANG, SS
    SONG, Z
    SWENDEMAN, SL
    SHEFFERY, M
    LICHTENSTEIN, LM
    ONO, SJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 285 - 285
  • [34] Cytoplasmic interleukin-4 (IL-4) and surface IL-4 receptor expression in patients with B-cell lymphocytic leukemia
    Kaminski, A
    Demaine, A
    Prentice, A
    BLOOD, 1998, 92 (06) : 2188 - 2189
  • [35] Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity
    Stäger, S
    Alexander, J
    Carter, KC
    Brombacher, F
    Kaye, PM
    INFECTION AND IMMUNITY, 2003, 71 (08) : 4804 - 4807
  • [36] INHIBITION OF BASOPHIL INTERLEUKIN-4 (IL-4) PRODUCTION BY INTERLEUKIN-8 (IL-8) AND BECLOMETHASONE (BECLO)
    FISHER, RH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 257 - 257
  • [37] Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM)
    Kyrstsonis, MC
    Dedoussis, G
    Baxevanis, C
    Stamatelou, M
    Maniatis, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 420 - 422
  • [38] Effects of in vivo administration of interleukin-4 (IL-4) to patients with myeloid leukemias.
    Venugopal, P
    Raza, A
    Jajeh, A
    Gregory, SA
    Gezer, S
    Cloutier, D
    Chopra, HK
    Mundle, S
    Sivaraman, S
    Yang, J
    Preisler, HD
    BLOOD, 1997, 90 (10) : 3856 - 3856
  • [39] IDENTIFICATION OF INTERLEUKIN-4 (IL-4) TARGET GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Alcaraz-Garcia, M. J.
    Ruiz-Lafuente, N.
    Sebastian-Ruiz, S.
    Gonzalez-Garcia, C.
    Majado, M. J.
    Parrado, A.
    HAEMATOLOGICA, 2012, 97 : 54 - 54
  • [40] Evaluation of interleukin-4 concentration by ELISA is influenced by the consumption of IL-4 by cultured cells
    Ewen, C
    Baca-Estrada, ME
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (01): : 39 - 43
12345